Adam Christian Thebesius
Adam Christian Thebesius (12 February 1686 – 10 November 1732) was a renowned German physician and anatomist. He is best known for his discovery of the Thebesian veins, a network of tiny veins in the heart that bear his name.
Early Life and Education[edit]
Thebesius was born in Sandau, Brandenburg, Germany. He studied medicine at the University of Halle, where he was influenced by the teachings of Friedrich Hoffmann, a prominent German physician and chemist of the time.
Career[edit]
After completing his studies, Thebesius practiced medicine in Halle and later in Dresden. His work primarily focused on anatomy, particularly the structure and function of the heart. In 1708, he published his seminal work, De circulo sanguinis in corde, in which he described the network of tiny veins in the heart that would later be named after him.
Thebesian Veins[edit]
The Thebesian veins, also known as the venae cordis minimae, are a network of tiny veins found in the walls of the heart. They are responsible for a small amount of the heart's blood supply and are named in honor of Thebesius, who first described them in his 1708 publication.
Legacy[edit]
Thebesius' work on the cardiovascular system has had a lasting impact on the field of cardiology. His discovery of the Thebesian veins has contributed to our understanding of the heart's blood supply and has implications for various heart conditions and treatments.
See Also[edit]
References[edit]
- De circulo sanguinis in corde (1708)
- Thebesius' Leben und Werk (1986)
-
Adam Christian Thebesius
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

